nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemifloxacin—Myalgia—Dactinomycin—muscle cancer	0.00365	0.00365	CcSEcCtD
Gemifloxacin—Abnormal dreams—Doxorubicin—muscle cancer	0.00364	0.00364	CcSEcCtD
Gemifloxacin—Eructation—Doxorubicin—muscle cancer	0.00362	0.00362	CcSEcCtD
Gemifloxacin—Anaemia—Vincristine—muscle cancer	0.00354	0.00354	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Etoposide—muscle cancer	0.00352	0.00352	CcSEcCtD
Gemifloxacin—Photosensitivity—Methotrexate—muscle cancer	0.00352	0.00352	CcSEcCtD
Gemifloxacin—Candida infection—Doxorubicin—muscle cancer	0.00352	0.00352	CcSEcCtD
Gemifloxacin—Skin exfoliation—Doxorubicin—muscle cancer	0.00352	0.00352	CcSEcCtD
Gemifloxacin—Oedema—Dactinomycin—muscle cancer	0.0035	0.0035	CcSEcCtD
Gemifloxacin—Urethral disorder—Etoposide—muscle cancer	0.0035	0.0035	CcSEcCtD
Gemifloxacin—Blood urea increased—Doxorubicin—muscle cancer	0.00348	0.00348	CcSEcCtD
Gemifloxacin—Vaginal infection—Doxorubicin—muscle cancer	0.00348	0.00348	CcSEcCtD
Gemifloxacin—Vertigo—Vincristine—muscle cancer	0.00344	0.00344	CcSEcCtD
Gemifloxacin—Leukopenia—Vincristine—muscle cancer	0.00343	0.00343	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Dactinomycin—muscle cancer	0.00343	0.00343	CcSEcCtD
Gemifloxacin—Cramps of lower extremities—Doxorubicin—muscle cancer	0.00338	0.00338	CcSEcCtD
Gemifloxacin—Erythema multiforme—Etoposide—muscle cancer	0.00337	0.00337	CcSEcCtD
Gemifloxacin—Renal failure acute—Methotrexate—muscle cancer	0.00334	0.00334	CcSEcCtD
Gemifloxacin—Anorexia—Dactinomycin—muscle cancer	0.00334	0.00334	CcSEcCtD
Gemifloxacin—Eye disorder—Etoposide—muscle cancer	0.00333	0.00333	CcSEcCtD
Gemifloxacin—Mouth ulceration—Doxorubicin—muscle cancer	0.00333	0.00333	CcSEcCtD
Gemifloxacin—Flushing—Etoposide—muscle cancer	0.00331	0.00331	CcSEcCtD
Gemifloxacin—Cardiac disorder—Etoposide—muscle cancer	0.00331	0.00331	CcSEcCtD
Gemifloxacin—Myalgia—Vincristine—muscle cancer	0.00326	0.00326	CcSEcCtD
Gemifloxacin—Angiopathy—Etoposide—muscle cancer	0.00324	0.00324	CcSEcCtD
Gemifloxacin—Immune system disorder—Etoposide—muscle cancer	0.00322	0.00322	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Etoposide—muscle cancer	0.00321	0.00321	CcSEcCtD
Gemifloxacin—Abnormal vision—Doxorubicin—muscle cancer	0.00321	0.00321	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00319	0.00319	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Vincristine—muscle cancer	0.00313	0.00313	CcSEcCtD
Gemifloxacin—Oedema—Vincristine—muscle cancer	0.00313	0.00313	CcSEcCtD
Gemifloxacin—Blood alkaline phosphatase increased—Doxorubicin—muscle cancer	0.00307	0.00307	CcSEcCtD
Gemifloxacin—Nervous system disorder—Vincristine—muscle cancer	0.00307	0.00307	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Vincristine—muscle cancer	0.00306	0.00306	CcSEcCtD
Gemifloxacin—Photosensitivity—Doxorubicin—muscle cancer	0.00304	0.00304	CcSEcCtD
Gemifloxacin—Decreased appetite—Dactinomycin—muscle cancer	0.00304	0.00304	CcSEcCtD
Gemifloxacin—Dysgeusia—Etoposide—muscle cancer	0.00304	0.00304	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Vincristine—muscle cancer	0.00302	0.00302	CcSEcCtD
Gemifloxacin—Fatigue—Dactinomycin—muscle cancer	0.00302	0.00302	CcSEcCtD
Gemifloxacin—Back pain—Etoposide—muscle cancer	0.003	0.003	CcSEcCtD
Gemifloxacin—Pain—Dactinomycin—muscle cancer	0.00299	0.00299	CcSEcCtD
Gemifloxacin—Muscle spasms—Etoposide—muscle cancer	0.00298	0.00298	CcSEcCtD
Gemifloxacin—Anorexia—Vincristine—muscle cancer	0.00298	0.00298	CcSEcCtD
Gemifloxacin—Eczema—Doxorubicin—muscle cancer	0.00298	0.00298	CcSEcCtD
Gemifloxacin—Renal failure acute—Doxorubicin—muscle cancer	0.0029	0.0029	CcSEcCtD
Gemifloxacin—Anaemia—Etoposide—muscle cancer	0.00287	0.00287	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00286	0.00286	CcSEcCtD
Gemifloxacin—Hot flush—Doxorubicin—muscle cancer	0.00286	0.00286	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00285	0.00285	CcSEcCtD
Gemifloxacin—Menopausal symptoms—Doxorubicin—muscle cancer	0.00283	0.00283	CcSEcCtD
Gemifloxacin—Insomnia—Vincristine—muscle cancer	0.00283	0.00283	CcSEcCtD
Gemifloxacin—Breast disorder—Methotrexate—muscle cancer	0.00279	0.00279	CcSEcCtD
Gemifloxacin—Vertigo—Etoposide—muscle cancer	0.00279	0.00279	CcSEcCtD
Gemifloxacin—Leukopenia—Etoposide—muscle cancer	0.00278	0.00278	CcSEcCtD
Gemifloxacin—Abdominal pain—Dactinomycin—muscle cancer	0.00277	0.00277	CcSEcCtD
Gemifloxacin—Body temperature increased—Dactinomycin—muscle cancer	0.00277	0.00277	CcSEcCtD
Gemifloxacin—Loss of consciousness—Etoposide—muscle cancer	0.00273	0.00273	CcSEcCtD
Gemifloxacin—Decreased appetite—Vincristine—muscle cancer	0.00272	0.00272	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Vincristine—muscle cancer	0.0027	0.0027	CcSEcCtD
Gemifloxacin—Fatigue—Vincristine—muscle cancer	0.0027	0.0027	CcSEcCtD
Gemifloxacin—Hyponatraemia—Doxorubicin—muscle cancer	0.00268	0.00268	CcSEcCtD
Gemifloxacin—Constipation—Vincristine—muscle cancer	0.00267	0.00267	CcSEcCtD
Gemifloxacin—Pain—Vincristine—muscle cancer	0.00267	0.00267	CcSEcCtD
Gemifloxacin—Eosinophilia—Methotrexate—muscle cancer	0.00264	0.00264	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00262	0.00262	CcSEcCtD
Gemifloxacin—Pancreatitis—Methotrexate—muscle cancer	0.00262	0.00262	CcSEcCtD
Gemifloxacin—Face oedema—Doxorubicin—muscle cancer	0.00258	0.00258	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Vincristine—muscle cancer	0.00256	0.00256	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Etoposide—muscle cancer	0.00253	0.00253	CcSEcCtD
Gemifloxacin—Asthenia—Dactinomycin—muscle cancer	0.00251	0.00251	CcSEcCtD
Gemifloxacin—Blood creatinine increased—Doxorubicin—muscle cancer	0.0025	0.0025	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Etoposide—muscle cancer	0.00248	0.00248	CcSEcCtD
Gemifloxacin—Tachycardia—Etoposide—muscle cancer	0.00247	0.00247	CcSEcCtD
Gemifloxacin—Abdominal pain—Vincristine—muscle cancer	0.00247	0.00247	CcSEcCtD
Gemifloxacin—Body temperature increased—Vincristine—muscle cancer	0.00247	0.00247	CcSEcCtD
Gemifloxacin—Skin disorder—Etoposide—muscle cancer	0.00246	0.00246	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Etoposide—muscle cancer	0.00245	0.00245	CcSEcCtD
Gemifloxacin—Photosensitivity reaction—Methotrexate—muscle cancer	0.00244	0.00244	CcSEcCtD
Gemifloxacin—Breast disorder—Doxorubicin—muscle cancer	0.00242	0.00242	CcSEcCtD
Gemifloxacin—Anorexia—Etoposide—muscle cancer	0.00242	0.00242	CcSEcCtD
Gemifloxacin—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.00241	0.00241	CcSEcCtD
Gemifloxacin—Diarrhoea—Dactinomycin—muscle cancer	0.0024	0.0024	CcSEcCtD
Gemifloxacin—Pneumonia—Methotrexate—muscle cancer	0.00239	0.00239	CcSEcCtD
Gemifloxacin—Infestation NOS—Methotrexate—muscle cancer	0.00238	0.00238	CcSEcCtD
Gemifloxacin—Infestation—Methotrexate—muscle cancer	0.00238	0.00238	CcSEcCtD
Gemifloxacin—Gastritis—Doxorubicin—muscle cancer	0.00237	0.00237	CcSEcCtD
Gemifloxacin—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00236	0.00236	CcSEcCtD
Gemifloxacin—Renal failure—Methotrexate—muscle cancer	0.00234	0.00234	CcSEcCtD
Gemifloxacin—Stomatitis—Methotrexate—muscle cancer	0.00232	0.00232	CcSEcCtD
Gemifloxacin—Dysphagia—Doxorubicin—muscle cancer	0.00231	0.00231	CcSEcCtD
Gemifloxacin—Eosinophilia—Doxorubicin—muscle cancer	0.00229	0.00229	CcSEcCtD
Gemifloxacin—Haematuria—Methotrexate—muscle cancer	0.00227	0.00227	CcSEcCtD
Gemifloxacin—Pancreatitis—Doxorubicin—muscle cancer	0.00227	0.00227	CcSEcCtD
Gemifloxacin—Dyspnoea—Etoposide—muscle cancer	0.00226	0.00226	CcSEcCtD
Gemifloxacin—Somnolence—Etoposide—muscle cancer	0.00225	0.00225	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Methotrexate—muscle cancer	0.00225	0.00225	CcSEcCtD
Gemifloxacin—Asthenia—Vincristine—muscle cancer	0.00224	0.00224	CcSEcCtD
Gemifloxacin—Vomiting—Dactinomycin—muscle cancer	0.00223	0.00223	CcSEcCtD
Gemifloxacin—Agranulocytosis—Methotrexate—muscle cancer	0.00222	0.00222	CcSEcCtD
Gemifloxacin—Rash—Dactinomycin—muscle cancer	0.00221	0.00221	CcSEcCtD
Gemifloxacin—Decreased appetite—Etoposide—muscle cancer	0.0022	0.0022	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Etoposide—muscle cancer	0.00219	0.00219	CcSEcCtD
Gemifloxacin—Fatigue—Etoposide—muscle cancer	0.00218	0.00218	CcSEcCtD
Gemifloxacin—Pain—Etoposide—muscle cancer	0.00217	0.00217	CcSEcCtD
Gemifloxacin—Constipation—Etoposide—muscle cancer	0.00217	0.00217	CcSEcCtD
Gemifloxacin—Haemoglobin—Methotrexate—muscle cancer	0.00215	0.00215	CcSEcCtD
Gemifloxacin—Diarrhoea—Vincristine—muscle cancer	0.00214	0.00214	CcSEcCtD
Gemifloxacin—Haemorrhage—Methotrexate—muscle cancer	0.00214	0.00214	CcSEcCtD
Gemifloxacin—Pharyngitis—Methotrexate—muscle cancer	0.00212	0.00212	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Methotrexate—muscle cancer	0.00211	0.00211	CcSEcCtD
Gemifloxacin—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00211	0.00211	CcSEcCtD
Gemifloxacin—Urethral disorder—Methotrexate—muscle cancer	0.00209	0.00209	CcSEcCtD
Gemifloxacin—Hyperglycaemia—Doxorubicin—muscle cancer	0.00208	0.00208	CcSEcCtD
Gemifloxacin—Nausea—Dactinomycin—muscle cancer	0.00208	0.00208	CcSEcCtD
Gemifloxacin—Pneumonia—Doxorubicin—muscle cancer	0.00207	0.00207	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Etoposide—muscle cancer	0.00207	0.00207	CcSEcCtD
Gemifloxacin—Dizziness—Vincristine—muscle cancer	0.00207	0.00207	CcSEcCtD
Gemifloxacin—Infestation NOS—Doxorubicin—muscle cancer	0.00206	0.00206	CcSEcCtD
Gemifloxacin—Infestation—Doxorubicin—muscle cancer	0.00206	0.00206	CcSEcCtD
Gemifloxacin—Visual impairment—Methotrexate—muscle cancer	0.00206	0.00206	CcSEcCtD
Gemifloxacin—Renal failure—Doxorubicin—muscle cancer	0.00203	0.00203	CcSEcCtD
Gemifloxacin—Erythema multiforme—Methotrexate—muscle cancer	0.00202	0.00202	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00202	0.00202	CcSEcCtD
Gemifloxacin—Urticaria—Etoposide—muscle cancer	0.00201	0.00201	CcSEcCtD
Gemifloxacin—Stomatitis—Doxorubicin—muscle cancer	0.00201	0.00201	CcSEcCtD
Gemifloxacin—Abdominal pain—Etoposide—muscle cancer	0.002	0.002	CcSEcCtD
Gemifloxacin—Body temperature increased—Etoposide—muscle cancer	0.002	0.002	CcSEcCtD
Gemifloxacin—Eye disorder—Methotrexate—muscle cancer	0.002	0.002	CcSEcCtD
Gemifloxacin—Vomiting—Vincristine—muscle cancer	0.00199	0.00199	CcSEcCtD
Gemifloxacin—Cardiac disorder—Methotrexate—muscle cancer	0.00198	0.00198	CcSEcCtD
Gemifloxacin—Rash—Vincristine—muscle cancer	0.00197	0.00197	CcSEcCtD
Gemifloxacin—Dermatitis—Vincristine—muscle cancer	0.00197	0.00197	CcSEcCtD
Gemifloxacin—Haematuria—Doxorubicin—muscle cancer	0.00196	0.00196	CcSEcCtD
Gemifloxacin—Headache—Vincristine—muscle cancer	0.00196	0.00196	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00195	0.00195	CcSEcCtD
Gemifloxacin—Angiopathy—Methotrexate—muscle cancer	0.00194	0.00194	CcSEcCtD
Gemifloxacin—Immune system disorder—Methotrexate—muscle cancer	0.00193	0.00193	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Methotrexate—muscle cancer	0.00193	0.00193	CcSEcCtD
Gemifloxacin—Agranulocytosis—Doxorubicin—muscle cancer	0.00192	0.00192	CcSEcCtD
Gemifloxacin—Mental disorder—Methotrexate—muscle cancer	0.00187	0.00187	CcSEcCtD
Gemifloxacin—Haemoglobin—Doxorubicin—muscle cancer	0.00186	0.00186	CcSEcCtD
Gemifloxacin—Nausea—Vincristine—muscle cancer	0.00186	0.00186	CcSEcCtD
Gemifloxacin—Haemorrhage—Doxorubicin—muscle cancer	0.00185	0.00185	CcSEcCtD
Gemifloxacin—Pharyngitis—Doxorubicin—muscle cancer	0.00184	0.00184	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Doxorubicin—muscle cancer	0.00183	0.00183	CcSEcCtD
Gemifloxacin—Oedema peripheral—Doxorubicin—muscle cancer	0.00182	0.00182	CcSEcCtD
Gemifloxacin—Dysgeusia—Methotrexate—muscle cancer	0.00182	0.00182	CcSEcCtD
Gemifloxacin—Asthenia—Etoposide—muscle cancer	0.00182	0.00182	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Doxorubicin—muscle cancer	0.00182	0.00182	CcSEcCtD
Gemifloxacin—Urethral disorder—Doxorubicin—muscle cancer	0.00181	0.00181	CcSEcCtD
Gemifloxacin—Back pain—Methotrexate—muscle cancer	0.0018	0.0018	CcSEcCtD
Gemifloxacin—Pruritus—Etoposide—muscle cancer	0.00179	0.00179	CcSEcCtD
Gemifloxacin—Visual impairment—Doxorubicin—muscle cancer	0.00178	0.00178	CcSEcCtD
Gemifloxacin—Erythema multiforme—Doxorubicin—muscle cancer	0.00175	0.00175	CcSEcCtD
Gemifloxacin—Diarrhoea—Etoposide—muscle cancer	0.00173	0.00173	CcSEcCtD
Gemifloxacin—Eye disorder—Doxorubicin—muscle cancer	0.00173	0.00173	CcSEcCtD
Gemifloxacin—Anaemia—Methotrexate—muscle cancer	0.00172	0.00172	CcSEcCtD
Gemifloxacin—Flushing—Doxorubicin—muscle cancer	0.00172	0.00172	CcSEcCtD
Gemifloxacin—Cardiac disorder—Doxorubicin—muscle cancer	0.00172	0.00172	CcSEcCtD
Gemifloxacin—Angiopathy—Doxorubicin—muscle cancer	0.00168	0.00168	CcSEcCtD
Gemifloxacin—Dizziness—Etoposide—muscle cancer	0.00168	0.00168	CcSEcCtD
Gemifloxacin—Immune system disorder—Doxorubicin—muscle cancer	0.00167	0.00167	CcSEcCtD
Gemifloxacin—Vertigo—Methotrexate—muscle cancer	0.00167	0.00167	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Doxorubicin—muscle cancer	0.00167	0.00167	CcSEcCtD
Gemifloxacin—Leukopenia—Methotrexate—muscle cancer	0.00166	0.00166	CcSEcCtD
Gemifloxacin—Mental disorder—Doxorubicin—muscle cancer	0.00162	0.00162	CcSEcCtD
Gemifloxacin—Vomiting—Etoposide—muscle cancer	0.00161	0.00161	CcSEcCtD
Gemifloxacin—Rash—Etoposide—muscle cancer	0.0016	0.0016	CcSEcCtD
Gemifloxacin—Dermatitis—Etoposide—muscle cancer	0.0016	0.0016	CcSEcCtD
Gemifloxacin—Headache—Etoposide—muscle cancer	0.00159	0.00159	CcSEcCtD
Gemifloxacin—Flatulence—Doxorubicin—muscle cancer	0.00159	0.00159	CcSEcCtD
Gemifloxacin—Arthralgia—Methotrexate—muscle cancer	0.00158	0.00158	CcSEcCtD
Gemifloxacin—Myalgia—Methotrexate—muscle cancer	0.00158	0.00158	CcSEcCtD
Gemifloxacin—Tension—Doxorubicin—muscle cancer	0.00158	0.00158	CcSEcCtD
Gemifloxacin—Dysgeusia—Doxorubicin—muscle cancer	0.00158	0.00158	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00157	0.00157	CcSEcCtD
Gemifloxacin—Nervousness—Doxorubicin—muscle cancer	0.00156	0.00156	CcSEcCtD
Gemifloxacin—Back pain—Doxorubicin—muscle cancer	0.00156	0.00156	CcSEcCtD
Gemifloxacin—Muscle spasms—Doxorubicin—muscle cancer	0.00155	0.00155	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Methotrexate—muscle cancer	0.00152	0.00152	CcSEcCtD
Gemifloxacin—Nausea—Etoposide—muscle cancer	0.0015	0.0015	CcSEcCtD
Gemifloxacin—Nervous system disorder—Methotrexate—muscle cancer	0.00149	0.00149	CcSEcCtD
Gemifloxacin—Anaemia—Doxorubicin—muscle cancer	0.00149	0.00149	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Methotrexate—muscle cancer	0.00149	0.00149	CcSEcCtD
Gemifloxacin—Skin disorder—Methotrexate—muscle cancer	0.00147	0.00147	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Methotrexate—muscle cancer	0.00147	0.00147	CcSEcCtD
Gemifloxacin—Vertigo—Doxorubicin—muscle cancer	0.00145	0.00145	CcSEcCtD
Gemifloxacin—Anorexia—Methotrexate—muscle cancer	0.00145	0.00145	CcSEcCtD
Gemifloxacin—Syncope—Doxorubicin—muscle cancer	0.00144	0.00144	CcSEcCtD
Gemifloxacin—Leukopenia—Doxorubicin—muscle cancer	0.00144	0.00144	CcSEcCtD
Gemifloxacin—Palpitations—Doxorubicin—muscle cancer	0.00142	0.00142	CcSEcCtD
Gemifloxacin—Loss of consciousness—Doxorubicin—muscle cancer	0.00142	0.00142	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00138	0.00138	CcSEcCtD
Gemifloxacin—Insomnia—Methotrexate—muscle cancer	0.00137	0.00137	CcSEcCtD
Gemifloxacin—Arthralgia—Doxorubicin—muscle cancer	0.00137	0.00137	CcSEcCtD
Gemifloxacin—Myalgia—Doxorubicin—muscle cancer	0.00137	0.00137	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00136	0.00136	CcSEcCtD
Gemifloxacin—Dyspnoea—Methotrexate—muscle cancer	0.00135	0.00135	CcSEcCtD
Gemifloxacin—Somnolence—Methotrexate—muscle cancer	0.00135	0.00135	CcSEcCtD
Gemifloxacin—Dry mouth—Doxorubicin—muscle cancer	0.00134	0.00134	CcSEcCtD
Gemifloxacin—Dyspepsia—Methotrexate—muscle cancer	0.00134	0.00134	CcSEcCtD
Gemifloxacin—Decreased appetite—Methotrexate—muscle cancer	0.00132	0.00132	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Doxorubicin—muscle cancer	0.00131	0.00131	CcSEcCtD
Gemifloxacin—Oedema—Doxorubicin—muscle cancer	0.00131	0.00131	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00131	0.00131	CcSEcCtD
Gemifloxacin—Fatigue—Methotrexate—muscle cancer	0.00131	0.00131	CcSEcCtD
Gemifloxacin—Pain—Methotrexate—muscle cancer	0.0013	0.0013	CcSEcCtD
Gemifloxacin—Shock—Doxorubicin—muscle cancer	0.00129	0.00129	CcSEcCtD
Gemifloxacin—Nervous system disorder—Doxorubicin—muscle cancer	0.00129	0.00129	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Doxorubicin—muscle cancer	0.00129	0.00129	CcSEcCtD
Gemifloxacin—Tachycardia—Doxorubicin—muscle cancer	0.00128	0.00128	CcSEcCtD
Gemifloxacin—Skin disorder—Doxorubicin—muscle cancer	0.00128	0.00128	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Doxorubicin—muscle cancer	0.00127	0.00127	CcSEcCtD
Gemifloxacin—Anorexia—Doxorubicin—muscle cancer	0.00125	0.00125	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Methotrexate—muscle cancer	0.00124	0.00124	CcSEcCtD
Gemifloxacin—Urticaria—Methotrexate—muscle cancer	0.00121	0.00121	CcSEcCtD
Gemifloxacin—Body temperature increased—Methotrexate—muscle cancer	0.0012	0.0012	CcSEcCtD
Gemifloxacin—Abdominal pain—Methotrexate—muscle cancer	0.0012	0.0012	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.0012	0.0012	CcSEcCtD
Gemifloxacin—Insomnia—Doxorubicin—muscle cancer	0.00119	0.00119	CcSEcCtD
Gemifloxacin—Dyspnoea—Doxorubicin—muscle cancer	0.00117	0.00117	CcSEcCtD
Gemifloxacin—Somnolence—Doxorubicin—muscle cancer	0.00117	0.00117	CcSEcCtD
Gemifloxacin—Dyspepsia—Doxorubicin—muscle cancer	0.00116	0.00116	CcSEcCtD
Gemifloxacin—Decreased appetite—Doxorubicin—muscle cancer	0.00114	0.00114	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00113	0.00113	CcSEcCtD
Gemifloxacin—Fatigue—Doxorubicin—muscle cancer	0.00113	0.00113	CcSEcCtD
Gemifloxacin—Pain—Doxorubicin—muscle cancer	0.00112	0.00112	CcSEcCtD
Gemifloxacin—Constipation—Doxorubicin—muscle cancer	0.00112	0.00112	CcSEcCtD
Gemifloxacin—Asthenia—Methotrexate—muscle cancer	0.00109	0.00109	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00107	0.00107	CcSEcCtD
Gemifloxacin—Pruritus—Methotrexate—muscle cancer	0.00107	0.00107	CcSEcCtD
Gemifloxacin—Urticaria—Doxorubicin—muscle cancer	0.00104	0.00104	CcSEcCtD
Gemifloxacin—Body temperature increased—Doxorubicin—muscle cancer	0.00104	0.00104	CcSEcCtD
Gemifloxacin—Abdominal pain—Doxorubicin—muscle cancer	0.00104	0.00104	CcSEcCtD
Gemifloxacin—Diarrhoea—Methotrexate—muscle cancer	0.00104	0.00104	CcSEcCtD
Gemifloxacin—Dizziness—Methotrexate—muscle cancer	0.001	0.001	CcSEcCtD
Gemifloxacin—Vomiting—Methotrexate—muscle cancer	0.000965	0.000965	CcSEcCtD
Gemifloxacin—Rash—Methotrexate—muscle cancer	0.000957	0.000957	CcSEcCtD
Gemifloxacin—Dermatitis—Methotrexate—muscle cancer	0.000956	0.000956	CcSEcCtD
Gemifloxacin—Headache—Methotrexate—muscle cancer	0.000951	0.000951	CcSEcCtD
Gemifloxacin—Asthenia—Doxorubicin—muscle cancer	0.000943	0.000943	CcSEcCtD
Gemifloxacin—Pruritus—Doxorubicin—muscle cancer	0.00093	0.00093	CcSEcCtD
Gemifloxacin—Nausea—Methotrexate—muscle cancer	0.000901	0.000901	CcSEcCtD
Gemifloxacin—Diarrhoea—Doxorubicin—muscle cancer	0.000899	0.000899	CcSEcCtD
Gemifloxacin—Dizziness—Doxorubicin—muscle cancer	0.000869	0.000869	CcSEcCtD
Gemifloxacin—Vomiting—Doxorubicin—muscle cancer	0.000836	0.000836	CcSEcCtD
Gemifloxacin—Rash—Doxorubicin—muscle cancer	0.000829	0.000829	CcSEcCtD
Gemifloxacin—Dermatitis—Doxorubicin—muscle cancer	0.000828	0.000828	CcSEcCtD
Gemifloxacin—Headache—Doxorubicin—muscle cancer	0.000823	0.000823	CcSEcCtD
Gemifloxacin—Nausea—Doxorubicin—muscle cancer	0.000781	0.000781	CcSEcCtD
